COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,789 Articles (22,946 medRxiv, 8,843 bioRxiv)

Most recent first Previous |  Page 807: Articles 8061-8070  | Next

Zooanthroponotic transmission of SARS-CoV-2 and host-specific viral mutations revealed by genome-wide phylogenetic analysis
Naderi, S., Chen, P., Murall, C. L., Poujol, R., Kraemer, S. A., Pickering, B. S., Sagan, S. M., Shapiro, B. J.
10.1101/2022.06.02.494559 — Posted: 2022-06-06
Origins and Evolution of Seasonal Human Coronaviruses
Otieno, J. R., Cherry, J. L., Spiro, D. J., Nelson, M. I., Trovao, N. S.
10.1101/2022.06.02.494567 — Posted: 2022-06-06
Transplantation of solid organs recovered from deceased donors recently infected by SARS-CoV-2 in the United States
Mamber Czeresnia, J., Tsai, H., Ajaimy, M., Tow, C. Y., Patel, S. R., Jorde, U. P., Madan, S., Hemmige, V.
10.1101/2022.06.05.22276008 — Posted: 2022-06-06
Pathogen-Host Adhesion between SARS-CoV-2 S Proteins from Different Variants and Human ACE2 Probed at Single-Molecule and Single-Cell Levels
Zhang, X., Chen, J., Hong, B., Xu, H., Pei, P., Chen, L., Tong, Y., Luo, S.-Z., Fan, H., He, C.
10.1101/2022.06.05.493249 — Posted: 2022-06-06
A uniquely stable trimeric model of SARS-CoV-2 spike transmembrane domain
Aliper, E. T., Krylov, N. A., Nolde, D. E., Polyansky, A. A., Efremov, R. G.
10.1101/2022.06.05.494856 — Posted: 2022-06-06
Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for SARS-CoV-2 3CL Protease
Hirose, Y., Shindo, N., Mori, M., Onitsuka, S., Isogai, H., Hamada, R., Hiramoto, T., Ochi, J., Takahashi, D., Ueda, T., Caaveiro, J. M. M., Yoshida, Y., Ohdo, S., Matsunaga, N., Toba, S., Sasaki, M., Orba, Y., Sawa, H., Sato, A., Kawanishi, E., Ojida, A.
10.1101/2022.06.05.494897 — Posted: 2022-06-06
Cross-Cultural Adaptation and Validation of the 5C Scale to Identify Factors Associated With COVID-19 and Influenza Vaccine Hesitancy Among Healthcare Workers in Cape Town, South Africa - A Protocol
Alobwede, S. M., Katoto, P., Cooper, S., Lumngwena, E., Kidzeru, E., Goliath, R., Jackson, A., Wiysonge, C., Shey, M.
10.1101/2022.06.06.22276038 — Posted: 2022-06-06
Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection
Khoury, D. S., Schlub, T. E., Cromer, D., Steain, M., Fong, Y., Gilbert, P. B., Subbarao, K., Triccas, J. A., Kent, S. J., Davenport, M. P.
10.1101/2022.06.05.22275943 — Posted: 2022-06-06
Does place connectivity moderate the association between concentrated disadvantage and COVID-19 fatality in the United States?
Jing, F., Li, Z., Qiao, S., Zhang, J., Olatosi, B., Li, X.
10.1101/2022.06.06.22276053 — Posted: 2022-06-06
On the origin of Omicron's unique Spike gene insertion
Venkatakrishnan, A., Anand, P., Lenehan, P. J., Suratekar, R., Raghunathan, B., Niesen, M. J., Soundararajan, V.
10.1101/2022.06.03.22275976 — Posted: 2022-06-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).